This inventor holds 2 USPTO granted patents. Top assignees: Biotheus Inc., Shanghai Zelgen Pharma.tech Co., Ltd., Suzhou Zelgen Biopharmaceuticals Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 7 
1 out of 1 
1 out of 1 Years Active: 2026
Title: Shifu Mo: Biopharmaceutical Inventor in Shanghai
Introduction
Shifu Mo is an inventor based in Shanghai, China, whose patent work focuses on antibody-based biopharmaceutical technology. His recorded patent activity includes an invention concerning an antibody that targets CD47.
Latest Patents
Mo is associated with one patent: “Anti-Human CD47 Antibody and Antigen-Binding Fragment Thereof, and Preparation Method Therefor and Use Thereof.” The invention covers an anti-human CD47 antibody and its antigen-binding fragment, along with methods for preparation and potential uses. His recorded portfolio includes 1 patent.
Career Highlights
Mo has worked with Suzhou Zelgen Biopharmaceuticals Co., Ltd. and Shanghai Zelgen Pharma.tech Co., Ltd. His patent work reflects involvement in biopharmaceutical research and the development of antibody-related technologies.
Collaborations
Mo’s listed coworkers include Liyun Gu and Yong Zhao. Their shared professional context connects them to work in the biopharmaceutical field.
Conclusion
Shifu Mo’s recorded invention centers on an anti-human CD47 antibody and its preparation and use, reflecting his contributions to biopharmaceutical innovation in Shanghai.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile